"10.1371_journal.pone.0032533","plos one","2012-02-28T00:00:00Z","Piero Ruggenenti; Flavio Gaspari; Antonio Cannata; Fabiola Carrara; Claudia Cella; Silvia Ferrari; Nadia Stucchi; Silvia Prandini; Bogdan Ene-Iordache; Olimpia Diadei; Norberto Perico; Patrizia Ondei; Antonio Pisani; Erasmo Buongiorno; Piergiorgio Messa; Mauro Dugo; Giuseppe Remuzzi; for the GFR-ADPKD Study Group","Clinical Research Center for Rare Diseases Aldo & Cele Daccò, Mario Negri Institute for Pharmacological Research, Bergamo, Italy; Unit of Nephrology, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy; Azienda Ospedaliera Universitaria Federico II, Napoli, Italy; Presidio Ospedaliero V. Fazzi, Lecce, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Azienda ULSS 9 – Ospedale S. Maria di Ca' Foncello, Treviso, Italy","Conceived and designed the experiments: PR FG GR NP. Performed the experiments: FG AC FC CC SF NS. Analyzed the data: CC FC BEI. Contributed reagents/materials/analysis tools: FG AC FC CC SF NS. Wrote the paper: PR FG GR NP. Contributed to data analyses and interpretation: PR FG GR NP. Wrote the initial draft of the manuscript: PR FG GR NP. Coordinated the activities of the Laboratory of the Clinical Research Center where all the GFR measurements were centralized: FG. Performed all the laboratory analyses: AC FC CC SF NS. Contributed to the statistical analyses: CC FC. Coordinated the activities of the Day Hospital of the Clinical Research Center where the clearance studies were performed: SP. Monitored all the activities of the clinical trials: OD. Generated the data bases and contributed to data handling: BE-I. Contributed to patient identification, monitoring and care: NP PO AP EB PM MD.","The authors have declared that no competing interests exist.","2012","02","Piero Ruggenenti","PR",18,FALSE,4,6,3,4,TRUE,FALSE,FALSE,0,NA,FALSE
